Literature DB >> 1253898

Cellular control of the tick-borne virus antigen production in persistently infected cell culture.

Y S Boriskin, N N Bogomolova.   

Abstract

The influence of inhibition or stimulation of cellular DNA synthesis on tick-borne virus antigen production in persistently infected cell culture was studied. Either mitomycin C or cytosine-arabinoside caused cessation of antigen-containing cell number increase. Stimulation of cellular DNA synthesis by growth medium change increased the level of antigen-containing cells. When HEp-2-Sof culture was synchronized, a correlation was observed between the entrance of cells into DNA synthesis phase and the increase of proportion of antigen-containing cells.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1253898     DOI： 10.1007/BF01940816

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  6 in total

1.  [Chronic infection of cells by tick-borne encephalitis virus. I. Cell properties of chronically infected cultures].

Authors:  O G ANDZHAPARIDZE; N N BOGOMOLOVA; S Ia ZALKIND
Journal:  Vopr Virusol       Date:  1962 Nov-Dec

2.  STUDIES OF THE LIFE CYCLE OF MAMMALIAN CELLS.

Authors:  T T PUCK
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1964

3.  Cell cycle dependent transcription of SV40 DNA in SV40-transformed cells.

Authors:  P Swetly; Y Watanabe
Journal:  Biochemistry       Date:  1974-09-24       Impact factor: 3.162

4.  Infectious DNA of tick-borne encephalitis virus.

Authors:  V M Zhdanov; N N Bogomolova; V I Gavrilov; O G Andzhaparidze; P G Deryabin; A N Astakhova
Journal:  Arch Gesamte Virusforsch       Date:  1974

5.  [Chronic infection of HEp-2 cells by tick-borne encephalitis virus. 6. Mitotic cycle parameters of the infected cells].

Authors:  R A Gibadulin; N N Bogomolova; O G Andzhaparidze
Journal:  Vopr Virusol       Date:  1970 Nov-Dec

6.  Cell-cycle dependent appearance of murine leukemia-sarcoma virus antigens.

Authors:  S Panem; V Schauf
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.